FI762698A7 - - Google Patents

Info

Publication number
FI762698A7
FI762698A7 FI762698A FI762698A FI762698A7 FI 762698 A7 FI762698 A7 FI 762698A7 FI 762698 A FI762698 A FI 762698A FI 762698 A FI762698 A FI 762698A FI 762698 A7 FI762698 A7 FI 762698A7
Authority
FI
Finland
Application number
FI762698A
Other languages
Finnish (fi)
Other versions
FI61482B (fi
FI61482C (fi
Inventor
Stefan Sanczuk
Hubert K Fr Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI762698A7 publication Critical patent/FI762698A7/fi
Publication of FI61482B publication Critical patent/FI61482B/fi
Application granted granted Critical
Publication of FI61482C publication Critical patent/FI61482C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI762698A 1975-09-23 1976-09-22 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-aryl-n-(1-l-4-piperidinyl)-arylacetamider FI61482C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US61513175 1975-09-23
US71375676A 1976-08-12 1976-08-12
US71375676 1976-08-12

Publications (3)

Publication Number Publication Date
FI762698A7 true FI762698A7 (enrdf_load_stackoverflow) 1977-03-24
FI61482B FI61482B (fi) 1982-04-30
FI61482C FI61482C (fi) 1982-08-10

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762698A FI61482C (fi) 1975-09-23 1976-09-22 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-aryl-n-(1-l-4-piperidinyl)-arylacetamider

Country Status (29)

Country Link
JP (1) JPS6016417B2 (enrdf_load_stackoverflow)
AT (1) AT363935B (enrdf_load_stackoverflow)
AU (1) AU510029B2 (enrdf_load_stackoverflow)
BG (1) BG27543A3 (enrdf_load_stackoverflow)
CA (1) CA1068271A (enrdf_load_stackoverflow)
CH (1) CH628623A5 (enrdf_load_stackoverflow)
CS (1) CS222663B2 (enrdf_load_stackoverflow)
DE (1) DE2642856A1 (enrdf_load_stackoverflow)
DK (1) DK150478C (enrdf_load_stackoverflow)
ES (1) ES451768A1 (enrdf_load_stackoverflow)
FI (1) FI61482C (enrdf_load_stackoverflow)
FR (1) FR2325377A1 (enrdf_load_stackoverflow)
GB (1) GB1539473A (enrdf_load_stackoverflow)
GR (1) GR58469B (enrdf_load_stackoverflow)
HU (1) HU172964B (enrdf_load_stackoverflow)
IE (1) IE43802B1 (enrdf_load_stackoverflow)
IL (1) IL50522A (enrdf_load_stackoverflow)
IT (1) IT1073893B (enrdf_load_stackoverflow)
LU (1) LU75837A1 (enrdf_load_stackoverflow)
NL (1) NL187267C (enrdf_load_stackoverflow)
NO (1) NO147672C (enrdf_load_stackoverflow)
NZ (1) NZ181972A (enrdf_load_stackoverflow)
PH (1) PH12497A (enrdf_load_stackoverflow)
PL (2) PL192578A1 (enrdf_load_stackoverflow)
PT (1) PT65631B (enrdf_load_stackoverflow)
RO (1) RO70079A (enrdf_load_stackoverflow)
SE (1) SE427839B (enrdf_load_stackoverflow)
SU (1) SU747424A3 (enrdf_load_stackoverflow)
YU (1) YU39973B (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
RU2489431C2 (ru) 2007-04-23 2013-08-10 Янссен Фармацевтика Н.В. Тиа(диа)золы как быстро диссоциирующие антагонисты рецептора допамина 2
DK2148873T3 (da) 2007-04-23 2012-11-26 Janssen Pharmaceutica Nv 4-alkoxypyridazinderivater som hurtigt dissocierende dopamin 2- receptorantagonister
AU2009266001B2 (en) 2008-07-03 2014-03-27 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-HT6 receptor antagonists
EP2307374B1 (en) 2008-07-31 2017-01-25 Janssen Pharmaceutica NV Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
PT65631B (en) 1978-07-05
SE427839B (sv) 1983-05-09
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
NO147672C (no) 1983-05-25
IE43802B1 (en) 1981-06-03
BG27543A3 (bg) 1979-11-12
FI61482B (fi) 1982-04-30
GR58469B (en) 1977-10-14
JPS5239683A (en) 1977-03-28
NL187267B (nl) 1991-03-01
NO147672B (no) 1983-02-14
IL50522A (en) 1979-09-30
PL192578A1 (pl) 1979-02-26
DE2642856C2 (enrdf_load_stackoverflow) 1990-06-21
PL117323B1 (en) 1981-07-31
HU172964B (hu) 1979-01-28
GB1539473A (en) 1979-01-31
IT1073893B (it) 1985-04-17
AU510029B2 (en) 1980-06-05
PT65631A (en) 1976-10-01
CS222663B2 (en) 1983-07-29
IL50522A0 (en) 1976-11-30
NL7610513A (nl) 1977-03-25
ATA702976A (de) 1981-02-15
NO763054L (no) 1977-03-24
DE2642856A1 (de) 1977-03-24
SE7610501L (sv) 1977-03-24
DK150478B (da) 1987-03-09
SU747424A3 (ru) 1980-07-23
DK427876A (da) 1977-03-24
AU1787876A (en) 1978-03-23
RO70079A (ro) 1982-10-26
IE43802L (en) 1977-03-23
CH628623A5 (en) 1982-03-15
ES451768A1 (es) 1978-05-01
JPS6016417B2 (ja) 1985-04-25
NZ181972A (en) 1978-07-28
FI61482C (fi) 1982-08-10
FR2325377A1 (fr) 1977-04-22
NL187267C (nl) 1991-08-01
AT363935B (de) 1981-09-10
PH12497A (en) 1979-04-05
YU39973B (en) 1985-06-30
LU75837A1 (enrdf_load_stackoverflow) 1977-05-04
CA1068271A (en) 1979-12-18
FR2325377B1 (enrdf_load_stackoverflow) 1980-04-18

Similar Documents

Publication Publication Date Title
JPS5237915U (enrdf_load_stackoverflow)
JPS5511483Y2 (enrdf_load_stackoverflow)
BG22021A1 (enrdf_load_stackoverflow)
BG22027A1 (enrdf_load_stackoverflow)
BG22326A1 (enrdf_load_stackoverflow)
BG22472A1 (enrdf_load_stackoverflow)
CH582460A5 (enrdf_load_stackoverflow)
CH587757A5 (enrdf_load_stackoverflow)
CH589430A5 (enrdf_load_stackoverflow)
CH589804A5 (enrdf_load_stackoverflow)
CH590025A5 (enrdf_load_stackoverflow)
CH592774B5 (enrdf_load_stackoverflow)
CH592898A5 (enrdf_load_stackoverflow)
CH592936A5 (enrdf_load_stackoverflow)
CH594804A5 (enrdf_load_stackoverflow)
CH595058A5 (enrdf_load_stackoverflow)
CH595660A5 (enrdf_load_stackoverflow)
CH595795A5 (enrdf_load_stackoverflow)
CH596979A5 (enrdf_load_stackoverflow)
CH597157A5 (enrdf_load_stackoverflow)
CH597366A5 (enrdf_load_stackoverflow)
CH597787A5 (enrdf_load_stackoverflow)
CH598569A5 (enrdf_load_stackoverflow)
CH598652A5 (enrdf_load_stackoverflow)
CH598885A5 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.